Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Governance Other
confidence 85%
filed 2026-07-01
Item 5.03
The disclosure reports stockholder approval and Board implementation of a 1-for-20 reverse stock split, effected through amendments to the Company's Restated Certificate of Incorporation. While a reverse stock split is a governance/capital structure matter rather than a named event type, it is material to investors as it affects share count, ownership percentages, and stock price mechanics. The event is clearly governance-related but does not fit the specific categories of exec_appointment, exec_departure, exec_compensation, or shareholder_vote_results (which typically refers to voting on directors or compensation plans rather than capital structure amendments).
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-07-01
EX-99.5
Marex Group plc completed its redomiciliation from England and Wales to Bermuda, effective 1 July 2026, following shareholder approval on 21 May 2026 and English High Court sanction on 26 June 2026, representing a significant change to the company's corporate structure and regulatory jurisdiction.
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-07-01
EX-99.1
This press release announces a 1-for-25 reverse split effective July 6, 2026, following shareholder authorization at the November 2025 Annual General Meeting and Board approval on June 4, 2026. While reverse splits are governance/capital structure actions, they are material to investors as they affect share count, trading price, and market perception. The disclosure is clearly governance-related but does not fit the specific named categories (exec appointment/departure, compensation, shareholder vote results, or auditor change), making governance_other the appropriate classification.
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-07-01
The 6-K discloses a reverse stock split (1-for-3) approved by the Board on May 4, 2026, effective July 6, 2026, reducing outstanding Class A Ordinary Shares from 10,259,764 to approximately 3,419,922. This is a governance and capital structure event that materially affects share count, trading mechanics, and convertible securities adjustments. While not a named governance type (exec appointment/departure, compensation, shareholder vote results), it is clearly a governance/corporate action matter that would affect a reasonable investor's assessment of share ownership and market mechanics.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-07-01
Item 7.01
The filing discloses termination of a Formal Agreement with the OCC dated January 14, 2025, effective June 30, 2026. The OCC stated that "the safety and soundness of the Bank and its compliance with the laws and regulations does not require the continued existence of the [Formal] Agreement." This represents a material regulatory milestone—resolution of a formal enforcement action—that affects the company's regulatory status, cost structure, and strategic flexibility. While this is fundamentally a regulatory/governance event rather than a specific named category (not a restatement, auditor change, or going-concern issue), it is clearly material to investors as it signals improved regulatory standing and expected cost reductions of over $5 million annually.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-07-01
Item 8.01
Dell Technologies completed its redomestication from a Delaware corporation to a Texas corporation, effective July 1, 2026, following stockholder approval at the June 2026 annual meeting. The redomestication resulted in material modifications to shareholder rights, including changes to derivative proceeding thresholds under Texas law versus Delaware law.
View raw filing on EDGAR →
8-K
Governance Other
confidence 77%
filed 2026-07-01
Item 5.03
Alight stockholders approved on June 10, 2026 three governance amendments: declassification of the Board, extension of officer exculpatory protection under Delaware law, and a 1-for-20 reverse stock split with corresponding authorized share reductions. The reverse stock split became effective on July 1, 2026, with Class A common stock beginning to trade on a split-adjusted basis on the NYSE under ticker 'ALIT' with a new CUSIP number.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-07-01
Item 8.01
The disclosure announces approval of a 1-for-10 reverse stock split by the board and majority stockholders on October 7, 2025. This is a governance event involving capital structure modification and shareholder approval, but does not fit the specific categories of exec_appointment, exec_departure, exec_compensation, or shareholder_vote_results (which typically refers to voting outcomes on discrete proposals). The reverse split is material to investors as it affects share count, trading price, and potential listing compliance, making it a governance_other event.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-07-01
Item 5.03
Stockholders approved a 1-for-18 reverse stock split on June 23, 2026, which was implemented via Certificate of Amendment filed June 30, 2026. This material capital structure modification reduces the outstanding share count from approximately 9.4 million to approximately 525,000 shares.
View raw filing on EDGAR →
6-K
Governance Other
confidence 92%
filed 2026-07-01
EX-99.1
This is a notice of general meeting convening shareholders to vote on approval of a US$2.0 billion share repurchase programme. The Board approved the programme on 7 May 2026, and shareholder approval is required under UK Companies Act 2006 section 694 to authorize off-market purchases of the Company's ordinary shares. While the document is a governance notice rather than a discrete event announcement, the underlying share repurchase authorization is material to shareholders as it represents a significant capital allocation decision affecting per-share value and shareholder returns.
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-06-30
The filing discloses amendment and restatement of the Company's Memorandum and Articles of Association on June 24, 2026, which restructured the authorized share capital and created a new dual-class share structure with Class A Ordinary Shares (1 vote each) and Class B Ordinary Shares (100 votes each). This is a governance event involving material changes to the capital structure and voting rights that would affect a reasonable investor's assessment of control and ownership dynamics, even though no exhibits were furnished with the 6-K body itself.
View raw filing on EDGAR →
8-K
Governance Other
confidence 72%
filed 2026-06-30
Item 8.01
The Company amended its Warrant Agency Agreement to extend the expiration date of publicly traded warrants from June 30, 2026 to September 30, 2026, and granted the Board discretion to reduce the exercise price and increase shares purchasable. This amendment materially affects the terms of outstanding securities and warrant holders' rights.
View raw filing on EDGAR →
8-K
Governance Other
confidence 65%
filed 2026-06-30
Item 3.03
The Company disclosed material modifications to the rights of security holders. The specific nature of these modifications cannot be fully determined from the Item classification alone, but the disclosure indicates a governance matter affecting shareholder or security holder rights.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-06-30
Item 8.01
The filing discloses a postponement of an extraordinary general meeting of shareholders scheduled to vote on a proposed initial business combination with BSTR Holdings, Inc. The meeting was rescheduled from July 2, 2026 to July 10, 2026, with the redemption deadline extended to July 8, 2026. While the underlying business combination is material (ma_activity), this Item 8.01 disclosure focuses on the procedural governance event—the postponement of the shareholder vote—rather than the substantive M&A transaction itself, which would be disclosed under Item 1.01 or 2.01. The postponement affects shareholder voting rights and timing, making it a governance matter that does not fit the specific shareholder_vote_results category (which applies to vote outcomes, not scheduling changes).
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-06-30
EX-99.1
Trident Digital Tech Holdings Ltd is soliciting shareholder votes at an Extraordinary General Meeting scheduled for July 8, 2026, on three material proposals: (1) share redesignation, increase of authorized capital from US$50,000 to US$1,200,000, and a 240-to-1 share consolidation; (2) adoption of amended memorandum and articles of association; and (3) conversion of US$8 million debt owed to the CEO into 901.4 million Class B shares. The notice and proxy materials disclose these material governance and capital-structure matters, though voting results are to be announced post-meeting.
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-06-30
EX-99.2
WF Holding Ltd is soliciting shareholder votes on seven material governance and capital structure proposals at an Extraordinary General Meeting scheduled for July 10, 2026, including authorization to increase authorized share capital from USD 50,000 to USD 25 billion, creation of a new Class A share class with 100 votes per share, redesignation of issued and unissued shares, amendment of memorandum and articles of association, and delegation of implementation authority to directors.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-06-30
Item 8.01
This disclosure concerns a shareholder meeting scheduled for July 10, 2026, to approve an amendment to the Company's articles of association extending the deadline for completing an initial business combination to January 16, 2027 (with optional extensions to July 16, 2027). The filing also describes the Company's and Sponsor's intent to enter into non-redemption agreements with unaffiliated shareholders, offering Class B ordinary shares as consideration for shareholders not redeeming their Class A shares. This is a governance matter involving shareholder voting and corporate structure amendments, not a specific named event type like shareholder vote results (which would apply post-vote) or a standard executive appointment/departure. The extension and non-redemption incentive structure are material to shareholders' assessment of the SPAC's timeline and capital preservation.
View raw filing on EDGAR →
8-K
Governance Other
confidence 73%
filed 2026-06-30
Item 5.03
Nu-Med Plus amended its articles of incorporation to create Series X Super Voting Preferred Stock and Series A Preferred Stock with distinct voting rights and privileges, materially modifying the rights of security holders and altering the company's capital structure and voting power.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-06-30
Item 3.03
The company established Series B Preferred Stock via a Certificate of Designations filed June 25, 2026, with senior liquidation preferences, an 18% dividend rate, protective provisions requiring two-thirds consent for certain corporate actions, and conversion rights. These modifications materially alter the capital structure and governance rights of existing common stockholders.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-06-30
Item 5.03
Atlantic International Corp. changed its corporate name to Circle8 Group, Inc., approved by the Board and filed with Delaware on June 29, 2026, effective immediately, with a corresponding ticker change to CIRC. The name change reflects the company's evolution into a global technology and workforce solutions platform.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-06-29
Item 8.01
The company's investment adviser waived 50% of subordinated income incentive fees for four fiscal quarters (Q2 2026 through Q1 2027) with no recoupment rights, materially reducing the company's operating costs during the waiver period.
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-06-29
EX-99.1
This is a transparency notification disclosing that Madison Avenue Partners crossed the 5% voting-rights threshold in Lakefront Biotherapeutics on June 15, 2026, acquiring 3,498,892 voting rights (5.31% of outstanding shares). While not a traditional governance event like an executive appointment or board change, this is a material shareholder disclosure under Belgian transparency legislation that would affect a reasonable investor's assessment of ownership structure and potential control dynamics. The event is governance-related (shareholder notification) but does not fit the specific named categories, making `governance_other` the appropriate classification.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-06-29
Item 8.01
The primary disclosure is the announcement of a preliminary proxy statement for a special shareholder meeting to vote on a share consolidation (1:5 to 1:20 ratio) intended to position TerrAscend for uplisting to a major U.S. stock exchange. While the filing also includes a segment presentation recast (New Jersey, Maryland, Pennsylvania), the salient event is the shareholder vote on the share consolidation, which is a governance matter. The consolidation is material to investors as it directly affects share structure and is a prerequisite for the company's stated uplisting strategy.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-06-29
This 8-K discloses a Shareholder Q&A document issued following the June 10, 2026 annual meeting. The filing references Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Exhibits), and the Q&A addresses shareholder-approved governance matters including a corporate name change from Triller Group Inc. to Eight Holdings Inc., authorization for a reverse stock split (which was effected on June 25, 2026 at 1-for-10), adoption of a 2026 Equity Incentive Plan, and Nasdaq 20% issuance approval for private placements. While the document contains strategic and operational commentary, the core disclosure event is governance-related—shareholder meeting outcomes and corporate identity/structure changes. The reverse split and name change are material governance actions affecting the registrant's public-company status and shareholder rights.
View raw filing on EDGAR →
6-K
Governance Other
confidence 70%
filed 2026-06-29
EX-99.1
Jin Medical International held shareholder meetings (Class A, Class B, and Extraordinary General Meeting) on July 9, 2026, to vote on multiple material proposals including a VIE acquisition, voting-rights changes (Class B voting rights increase from 30 to 800 votes per share), a related-party share repurchase of 3.77M Class A shares from CEO Wang Erqi's entity (Jolly Harmony) at 90-day VWAP, and issuance of 3.77M Class B shares to the same entity, as well as authorized capital increase.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-06-29
Item 5.03
GD Culture Group effected a 1-for-250 reverse stock split of its authorized and issued shares, approved by the Board on June 16, 2026 and effective June 29, 2026, consolidating approximately 1.04 billion shares into approximately 4.16 million shares. The reverse split was previously approved by stockholders on December 31, 2025, and a Certificate of Change was filed with Nevada's Secretary of State on June 18, 2026. This capital structure adjustment affects all shareholders uniformly and impacts the company's trading characteristics on Nasdaq.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-06-29
Item 7.01
The company announced its inclusion in the Russell Microcap® Index effective June 29, 2026, which enhances market visibility and is material to institutional investors due to its impact on investment flows and index-tracking fund participation.
View raw filing on EDGAR →
8-K
Governance Other
confidence 72%
filed 2026-06-29
Item 3.03
The Company disclosed a material modification to the rights of security holders, which incorporates amendments to the Certificate of Incorporation and related governance documents affecting voting power, dividend rights, or other fundamental security characteristics.
View raw filing on EDGAR →
6-K
Governance Other
confidence 65%
filed 2026-06-29
EDENOR disclosed an upgrade of its issuer credit rating by S&P National Ratings from "raA+" to "raAA-", with outlook change from positive to stable. While credit rating changes are material to investors assessing financial risk and cost of capital, they do not fit neatly into the standard 8-K taxonomy. The disclosure is governance-adjacent (relating to the company's financial standing and market perception) rather than a discrete operational, financial, or legal event. Classified as governance_other because the domain is clearly governance/market-related but no specific named type applies.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-06-29
Item 5.03
Stockholders approved and the board adopted amendments to NRC Health's certificate of incorporation and bylaws that materially alter the Company's governance structure, including removal of supermajority voting requirements, elimination of restrictions on director removal without cause, and lowering the threshold for stockholder action by written consent from unanimous to a simple majority.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-06-29
Item 5.03
Barrel Energy Inc. filed a Corrective Amendment to its Certificate of Designation for Series A Preferred Stock on June 22, 2026, clarifying a 1:1,000 conversion ratio for 5 million preferred shares, representing 5 billion shares of common stock upon conversion. This amendment materially modifies shareholder rights and represents significant potential dilution to existing shareholders' equity and voting power.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-06-29
Ocean Power Technologies amended and restated its Section 382 Tax Benefits Preservation Plan on June 29, 2026, extending the expiration date from June 29, 2026 to June 29, 2029. This is a governance matter involving modification of shareholder rights and anti-takeover protections. While the plan protects valuable NOL tax attributes (a financial benefit), the core disclosed action is a governance/structural change to the rights preservation mechanism itself, making governance_other the most appropriate classification. The materiality is high given the company's reliance on NOLs and the plan's role in deterring ownership changes that could limit tax benefits.
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-06-29
EX-99.1
The exhibit announces a 1-for-9 share consolidation of Class A and Class B ordinary shares, effective July 2, 2026, approved by the board on June 7, 2026 without shareholder vote. This is a capital structure modification that affects all shareholders' holdings and the company's equity profile. While not a traditional governance event (board election, audit change, or shareholder vote), it is a material corporate action that restructures the equity base and is disclosed as a governance decision by the board under its delegated authority under the BVI Business Companies Act.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-06-29
Item 3.03
Rockwell Medical implemented a 1-for-10 reverse stock split, effective July 1, 2026, following stockholder approval at the June 12, 2026 annual meeting. The company filed a certificate of amendment with Delaware to effect this material modification to the rights and structure of its outstanding securities.
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-06-29
EX-99.2
The SEC declared NuRAN Wireless's Form 40-F registration statement effective as of June 26, 2026, removing a critical regulatory barrier to the Company's Nasdaq listing and opening access to U.S. institutional and retail investors.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-06-29
Item 6.02
This Item 6.02 discloses a change in servicer: Greystone Servicing Company LLC was removed as special servicer and CWCapital Asset Management LLC (CWCAM) was appointed as successor special servicer effective June 29, 2026, pursuant to the Pooling and Servicing Agreement. While the filing includes extensive background on CWCAM's qualifications and litigation history, the core event is a servicer transition—a governance/administrative change in the trust structure. This is material to certificateholders as it affects who manages the underlying mortgage loans and REO properties.
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-06-26
EX-99
This disclosure announces the conclusion of a legal review initiated following Mr. Atanu Chakraborty's resignation as an executive officer. The external law firms (Wilson Sonsini and Wadia Ghandy) conducted a three-month investigation into concerns raised in his resignation letter and found his allegations unsubstantiated. While the resignation itself occurred earlier (March 24, 2026), this announcement of the legal review's outcome is a governance event addressing the integrity of board processes and management conduct — material to investors assessing the bank's governance and leadership credibility.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-06-26
Item 3.03
Quince Therapeutics effectuated a 1-for-20 reverse stock split on June 26, 2026, pursuant to stockholder approval obtained on June 11, 2026, via a Certificate of Amendment filed with Delaware. The reverse split modifies the capital structure and trading characteristics of the company's common stock by combining shares, though it does not alter ownership percentages or the fundamental rights and preferences of the securities.
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-06-26
EX-99.1
The Company completed a 1-for-16 share consolidation effective June 22, 2026, which was approved by shareholders on May 28, 2026 and the board on May 14, 2026. The consolidation was undertaken to maintain Nasdaq listing compliance and materially changes the share count and trading mechanics, including assignment of a new CUSIP.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-06-26
Item 8.01
The disclosure describes a reincorporation of DeFi Development Corp. from Delaware to Nevada, effective June 26, 2026. This is a governance event involving a change in the state of incorporation and the governing corporate documents (Nevada Charter and Nevada Bylaws replacing Delaware Certificate of Incorporation and Bylaws). While the company explicitly states the reincorporation did not change headquarters, business, management, properties, or material contracts, a change in state of incorporation is a material governance matter that affects stockholder rights and the legal framework governing the company's internal affairs. This does not fit the specific governance categories (exec_departure, exec_appointment, exec_compensation, auditor_change, shareholder_vote_results) but is clearly a material governance restructuring.
View raw filing on EDGAR →
6-K
Governance Other
confidence 75%
filed 2026-06-25
The 6-K discloses shareholder approval for "reclassification of certain members of the promoter and promoter group" dated June 25, 2026. This is a governance matter involving changes to promoter classification status, which affects the company's ownership structure and regulatory standing. While the specific details are in the attached Exhibit 99.1 (not provided), the intimation of shareholder approval for promoter reclassification is material to investors assessing control and related-party dynamics.
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-06-25
EX-99.1
This announcement discloses NetEase's conversion from a secondary to dual-primary listing on the Hong Kong Exchange, effective June 30, 2026, triggered by migration of 55% of trading volume to HK markets. The disclosure addresses governance and regulatory compliance matters—shareholder approvals obtained at the June 23, 2026 AGM for share issuance mandates, share repurchase mandates, amendment of the 2019 share incentive plan, and amendments to memorandum and articles of association to comply with HK Listing Rules. The company also obtained waivers for continued use of U.S. GAAP and for contractual arrangements (VIE structure). While primarily a listing-status and regulatory-compliance matter, the conversion materially affects the company's governance obligations and disclosure requirements going forward, making it material to investors assessing the registrant's regulatory posture and operational structure.
View raw filing on EDGAR →
8-K
Governance Other
confidence 65%
filed 2026-06-25
Item 5.03
Effective upon the merger's consummation, the company amended its certificate of incorporation and bylaws, and the board of directors was reconstituted with director departures and appointments reflecting the change of control.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-06-25
Item 8.01
This Item 8.01 disclosure supplements a definitive proxy statement for a pending business combination by announcing the addition of two independent director nominees (William Koschak and Jonathan Bond) to the combined entity's board following the Business Combination. While the section also includes business development updates regarding product shipments and hospital projects, the primary governance action is the appointment of these directors and their committee assignments. This is a material governance event affecting the post-combination board composition, though it is technically supplemental disclosure to an already-filed proxy rather than a standalone appointment announcement.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-06-25
The filing discloses multiple governance events: (1) appointment of two independent directors (Kelly Ulto and Greg Shilling) with significant expertise in audit, finance, and healthcare technology; (2) transition of Benedetta Casamento from Board Chair to Executive Chair with expanded strategic responsibilities; and (3) restructuring of Leonard Osser's role from Managing Director to Advisor with modified compensation. While Item 5.02 covers director appointments and executive compensation, the primary focus is the comprehensive governance restructuring and board strengthening, which is material to investors assessing leadership and oversight capabilities.
View raw filing on EDGAR →
6-K
Governance Other
confidence 80%
filed 2026-06-25
EX-99.2
GIBO Holdings implemented a 25-for-1 share consolidation effective June 29, 2026, approved by shareholders at an April 6, 2026 extraordinary general meeting. The consolidation affected both Class A and Class B ordinary shares, adjusted warrant exercise prices and share counts, and resulted in a new CUSIP, materially impacting share value, marketability, and warrant economics.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-06-25
Item 5.03
This disclosure concerns a certificate of amendment to the Company's Certificate of Incorporation filed on June 24, 2026, which amended Article IV to authorize a new capital structure and effect a recapitalization converting outstanding shares into 316,939,750 shares. While the recapitalization is part of a broader spin-off distribution plan, the Item 5.03 filing itself focuses on the governance/charter amendment mechanics rather than the M&A activity itself. The amendment is material to investors as it restructures the Company's capitalization in connection with the announced distribution, but it is fundamentally a governance/charter matter rather than a specific M&A event type.
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-06-24
EX-99.1
This is a major shareholder announcement disclosing that OCM Njord Holdings S.à r.l. (affiliated with Oaktree Capital Group Holdings GP, LLC) holds 20,329,874 shares representing 19.86% of TORM plc's total share capital and voting rights. The disclosure is made in accordance with section 30 of the Danish Capital Markets Act, a governance-mandated transparency requirement. While not a traditional executive appointment or departure, this substantial ownership stake disclosure is material to investors' understanding of the company's control structure and governance.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-06-24
Item 8.01
The Board of Trustees approved a material change to the Fund's 80% investment policy effective August 28, 2026, broadening the definition of eligible investments to include "income-producing investments" beyond traditional corporate debt, and expanding the types of instruments that may be counted toward the policy. This is a governance decision affecting the Fund's fundamental investment mandate and requires 60-day shareholder notice, making it material to investors' understanding of the Fund's strategy and operations.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-06-24
Item 8.01
The Board of Trustees approved a material change to the Fund's 80% investment policy effective August 28, 2026, broadening the definition of eligible investments to include income-producing investments beyond corporate debt obligations. This is a governance event—a board-approved policy amendment affecting the Fund's investment mandate—that would materially affect investor expectations about the Fund's portfolio composition and risk profile. While not a named governance category (such as an executive appointment or auditor change), it clearly falls within governance-related matters requiring board approval and shareholder notification.
View raw filing on EDGAR →